Zachary Winkler, MD
Pain Medicine · Colorado Springs, CONPI 1417338203
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,645 of the $9,162 with a category attached, or 72.5%. 37 manufacturers reported payments, led by Nevro Corp. at 25.8% of the total.
Across 344 payments — averaging $26.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$2K
- Abbott$2K
- Boston Scientific$1K
- Collegium Pharmaceutical, Inc.$450
- SPR Therapeutics, Inc$358
- Medtronic$321
- plus $3K from 31 others
What the payments were for
- Travel & lodging$2,51627%
- Food & beverage$6,64573%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 20 | $2,368 |
| Abbott | 99 | $1,945 |
| Boston Scientific | 40 | $1,171 |
| Collegium Pharmaceutical, Inc. | 28 | $450 |
| SPR Therapeutics, Inc | 17 | $358 |
| Medtronic | 14 | $321 |
| AbbVie(2 entities) | 20 | $312 |
| Scilex Pharmaceuticals Inc. | 15 | $258 |
| Aurora Spine, Inc. | 1 | $209 |
| Almatica Pharma LLC | 12 | $191 |
| Amgen(2 entities) | 11 | $174 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $174 |
| Pfizer | 3 | $158 |
| Redhill Biopharma Inc. | 7 | $120 |
| Vertos Medical, Inc. | 5 | $103 |
| Saluda Medical Americas, Inc. | 3 | $102 |
| Lundbeck LLC | 3 | $71 |
| Lilly USA, LLC | 5 | $71 |
| Averitas Pharma Inc. | 3 | $64 |
| Tersera Therapeutics LLC | 2 | $62 |
| Biodelivery Sciences International, Inc. | 3 | $53 |
| Relievant Medsystems, Inc. | 1 | $51 |
| Novartis | 3 | $48 |
| Forte Bio-pharma LLC | 1 | $47 |
| Indivior Inc. | 2 | $33 |
| GRT US Holding, Inc. | 2 | $31 |
| Curonix LLC | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $28 |
| IBSA Pharma Inc. | 1 | $21 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Stryker | 1 | $20 |
| Vertex | 1 | $19 |
| Trevena, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Orexo US, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$2,022
- PROCLAIM$985
- SPECTRA WAVEWRITER$367
- ZIP$209
- ETERNA$182
- WaveWriter Alpha Prime 16$146
- ZAVZPRET$122
How this compares
$9,162 in reported general payments places this provider in the 80th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 593 | $139,605 |
| BelbucaBuprenorphine Hcl | 159 | $95,018 |
| RelistorMethylnaltrexone Bromide | 22 | $54,705 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 299 | $49,733 |
| Nucynta ErTapentadol Hcl | 42 | $43,048 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,615 | $35,223 |
| Xtampza ErOxycodone Myristate | 40 | $28,964 |
| Lidocaine | 314 | $26,976 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 997 | $24,212 |
| MovantikNaloxegol Oxalate | 42 | $17,776 |
| OxycontinOxycodone Hcl | 21 | $16,610 |
| ZtlidoLidocaine | 44 | $15,737 |
| Gabapentin | 1,338 | $14,681 |
| Diclofenac Sodium | 166 | $10,877 |
| SymproicNaldemedine Tosylate | 22 | $10,344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Buprenorphine Hcl, Morphine Sulfate | $20 | $195,4711,083 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Xtampza Er | $450 | $167,030241 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $174 | $54,70522 claims |
| Redhill Biopharma Inc.Movantik | $120 | $17,77642 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $258 | $15,73744 claims |
| AbbVieLinzess | $312 | $6,69913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 96 pain medicine providers in Colorado.
Other pain medicine in Colorado Springs
- Mark MeyerColorado Springs$14K
- Jennifer WindsorColorado Springs$9K
- Vladislav SuntsovColorado Springs$9K
- Joshua RockColorado Springs$9K
- Anthony NguyenColorado Springs$7K
- Christopher MalinkyColorado Springs$5K
- Morgan DahmsColorado Springs$5K
- Tyler NickleColorado Springs$4K
- William LippertColorado Springs$3K
- Timothy SandellColorado Springs$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.